@dansfera: Clinical trials are notorious for hitting walls, but what if the trick isn't eliminating bottlenecks, but moving them? This perspective argues that shifting the focus upstream keeps patients in the loop longer, turning a standard operational headache into a real opportunity for growth and retention. Because, let’s be honest—the entire industry is just one big sequence of bottlenecks anyway. Why not fix the ones that actually matter? #clinicaltrials #biotech #pharmaceuticals #healthcareinnovation #clinicalresearch